Inspire Medical Systems Cash Flow Statement
NYSE: INSPHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Inspire Medical Systems free cash flow
In fiscal 2025, Inspire Medical Systems generated $117.0 million of operating cash flow and spent $38.5 million on capital expenditures. That left free cash flow of $78.5 million, a free-cash-flow margin of 8.6% of revenue. Free cash flow was down 13.9% from the prior year's $91.1 million.
Inspire Medical Systems returned $175.0 million to shareholders through share repurchases, equal to 223% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Inspire Medical Systems cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 145.42M | 53.51M | -21.15M | -44.88M | -42.04M | -57.20M | -33.24M | -21.83M | -17.51M |
| Net Income growth (YoY) | +171.77% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 13.96M | 6.55M | 2.85M | 1.86M | 1.22M | 840.00K | 495.00K | 393.00K | 285.00K |
| Stock-Based Compensation | 130.26M | 116.01M | 82.47M | 51.97M | 26.18M | 12.82M | 6.20M | 1.22M | 243.00K |
| Change in Working Capital | -93.50M | -50.58M | -47.68M | -10.13M | -13.91M | -12.02M | -9.52M | 861.00K | 777.00K |
| Operating Cash Flow | 116.98M | 130.25M | 24.65M | 11.57M | -20.12M | -53.05M | -32.85M | -18.69M | -15.79M |
| Capital Expenditures | -38.50M | -39.12M | -23.63M | -9.10M | -4.67M | -2.46M | -2.74M | -250.00K | -412.00K |
| Investing Cash Flow | 21.45M | -113.12M | -294.82M | -19.60M | 29.14M | 86.63M | -43.56M | -83.39M | -7.60M |
| Share Repurchases | -175.02M | 0 | 0 | 0 | — | — | — | — | — |
| Debt Repaid | — | 0 | 0 | -24.50M | 0 | 0 | — | — | — |
| Financing Cash Flow | -183.45M | -52.39M | 13.95M | 235.08M | 14.95M | 134.06M | 1.96M | 190.38M | 25.66M |
| Net Change in Cash | -45.34M | -35.39M | -256.06M | 227.13M | 23.95M | 167.66M | -74.43M | 88.33M | 2.27M |
| Free Cash Flow | 78.48M | 91.12M | 1.02M | 2.47M | -24.79M | -55.50M | -35.59M | -18.94M | -16.20M |
This table shows 9 annual periods of Inspire Medical Systems's cash flow statement, from FY 2025 back to FY 2017, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INSP's reporting calendar. What is a cash flow statement?